Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
Clinical trial NCT07110415 · RECRUITING
Trial details
- NCT number
- NCT07110415
- Sponsor
- SPH Qingdao Growful Pharmacetical Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-06
- Primary completion
- 2030-08-31
- Enrollment
- 2708
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.